UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?

被引：0
|
作者：
Ojeda-Fernandez, Luisa [1 ,4 ]
Baviera, Marta [1 ]
Macaluso, Giulia [1 ]
Schena, Simone [1 ]
Tettamanti, Mauro [1 ]
Cartabia, Massimo [1 ]
Foresta, Andreana [1 ]
Manucci, Pier Manuccio [2 ,3 ]
Nobili, Alessandro [1 ]
Remuzzi, Giuseppe [1 ]
Roncaglioni, Carla [1 ]
机构：
[1] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] Univ Milan, Milan, Italy
[4] Ist Ric Farmacol Mario Negri IRCCS, Dept Hlth Policy, Lab Cardiovasc Prevent, Via Mario Negri 2, I-20156 Milan, Italy
来源：
JOURNAL OF INTERNAL MEDICINE | 2024年 / 295卷 / 01期
关键词：
D O I：
10.1111/joim.13711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：110 / 112
页数：3
相关论文
共 50 条
  • [1] Vitamin C for COVID-19 Treatment: Have We Got Enough Evidence?
    Ahmad, Siti Rohaiza
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [2] Drug Repurposing in the Treatment of COVID-19
    Soylu, Mehmet
    Ozbek, Emine Nur
    Yetik Anacak, Gunay
    [J]. BEZMIALEM SCIENCE, 2020, 8 : 84 - 93
  • [3] Drug repurposing for the treatment of COVID-19
    Kato, Yuri
    Nishiyama, Kazuhiro
    Nishimura, Akiyuki
    Noda, Takamasa
    Okabe, Kaori
    Kusakabe, Takahiro
    Kanda, Yasunari
    Nishida, Motohiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 149 (03) : 108 - 114
  • [4] Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira, Vitoria Andrade
    Costa, Larissa Braga
    Perez, Lucas Giandoni
    Ribeiro, Victor Teatini
    Lanza, Katharina
    Simoes e Silva, Ana Cristina
    [J]. CLINICS, 2020, 75 : e1928
  • [5] Do We have the Evidence to Repurpose Levamisole for Treatment COVID 19?
    Mukhopadhyay, Keshab
    Dalai, Chanchal Kumar
    Singh, Ritesh
    Ahmed, Shah Newaz
    Banerjee, Kushal
    [J]. CURRENT DRUG THERAPY, 2021, 16 (02) : 142 - 147
  • [6] Systematic Review on Treatment Trials of Tocilizumab: A Repurposing Drug against COVID-19
    Banerjee, Shilpita
    Mahapatra, Ajit Kumar
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2021, 16 (04) : 381 - 389
  • [7] Antineoplasic drug repurposing in hematology for COVID-19 treatment
    Tazi, Illias
    [J]. BULLETIN DU CANCER, 2021, 108 (04) : 435 - 437
  • [8] Drug repurposing against COVID-19: focus on anticancer agents
    Ciliberto, Gennaro
    Mancini, Rita
    Paggi, Marco G.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [9] Drug repurposing against COVID-19: focus on anticancer agents
    Gennaro Ciliberto
    Rita Mancini
    Marco G. Paggi
    [J]. Journal of Experimental & Clinical Cancer Research, 39
  • [10] Do we have enough evidence to insist we have IVUS?
    Starkey, IR
    [J]. HEART, 1997, 78 : 30 - 30
12345